Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: James Young who wrote (505)	3/18/1997 3:55:00 PM
From: Jorgen Jensen	of 6136

To all: Tuesday March 18 3:00 PM EST Agouron Pharmaceuticals Inc knows no reason for stock drop LOS ANGELES, March 18 (Reuter) - Agouron Pharmaceuticals Inc said Monday it knew of no reason for the sharp drop in its share price, which follows the long-awaited approval last week of its Viracept AIDS drug. Agouron shares were down 5-1/2 to 75. "We haven't a clue what's going on with the stock. It's ridiculous," said Agouron spokeswoman Donna Nichols. "The market is not being very kind to us at the moment." Nichols said that the early sales and distribution of Viracept were proceeding smoothly. Analysts speculated that the stock was hit by profit taking after a run-up ahead of the U.S. Food and Drug Administration approval and noted that it was a generally down day for the biotech sector. Other losers in the group included Biogen Inc , down 2-1/16 to 39-15/16; Centocor Inc , down 1-7/8 to 30-1/8; and Genzyme Corp , off 1-1/4 to 23-3/8.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next